Article
Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.
Oncotarget - 23 May 2017
Lindquist Kajsa Ericson, Karlsson Anna, Levéen Per, Brunnström Hans, Reuterswärd Christel, Holm Karolina, Jönsson Mats, Annersten Karin, Rosengren Frida, Jirström Karin, Kosieradzki Jaroslaw, Ek Lars, Borg Åke, Planck Maria, Jönsson Göran, Staaf Johan
Abstract excerpt
Precision medicine requires accurate multi-gene clinical diagnostics. We describe the implementation of an Illumina TruSight Tumor (TST) clinical NGS diagnostic framework and parallel validation of a NanoString RNA-based ALK, RET, and ROS1 gene fusion assay for combined analysis of treatment predictive alterations in non-small cell lung cancer (NSCLC) in a regional healthcare region of Sweden (Scandinavia). The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
